Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women
about
Methylation analysis and HPV genotyping of self-collected cervical samples from women not responding to screening invitation and review of the literature.Triage of high-risk HPV positive women in cervical cancer screening.Management of high-risk HPV-positive women for detection of cervical (pre)cancer.Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer.Gene promoter methylation and protein expression of BRMS1 in uterine cervix in relation to high-risk human papilloma virus infection and cancer.FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women.Methylation of HPV and a tumor suppressor gene reveals anal cancer and precursor lesions.Methyltransferase G9a promotes cervical cancer angiogenesis and decreases patient survival.Performance of a methylation specific real-time PCR assay as a triage test for HPV-positive women.Candidate biomarkers in the cervical vaginal fluid for the (self-)diagnosis of cervical precancer.Randomised study shows that repeated self-sampling and HPV test has more than two-fold higher detection rate of women with CIN2+ histology than Pap smear cytology.Human Papillomavirus DNA methylation as a biomarker for cervical precancer: Consistency across 12 genotypes and potential impact on management of HPV-positive women.Methylated genomic loci encoding microRNA as a biomarker panel in tissue and saliva for head and neck squamous cell carcinoma.Detection of hypermethylated genes as markers for cervical screening in women living with HIVHost-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer
P2860
Q36298250-89B79FFC-5230-494E-9339-A7E5FDFAED43Q38824019-D8553331-6589-4A19-8354-5505A1B378CBQ38837737-2AEFCEF7-9174-4765-A342-849E4B53ADC8Q40202976-E334D399-ED87-47BF-84D3-F5F13BAB990FQ40256293-74888EBA-2694-4CE8-BEC6-051358667D09Q40651861-3A2A8D11-DF10-4A93-B909-3D83C51B922CQ41612137-04564653-C563-40ED-BF00-027A47C8CE1BQ41808271-4EF56DDC-9088-4710-A47D-EB962CF2E73AQ43719974-F2798FC2-7577-4F0C-99B2-55D401C98E52Q47397671-2A4F36CF-5087-4D7F-967A-B939369937D9Q50041872-05A178C1-9EED-4C85-88F6-0FC3FCCCEB9DQ50115891-5E7A3755-EF0E-4D66-9AB7-E7802649513DQ52595140-6B444A8A-C51D-4086-B36C-A249D7EAB228Q56941300-985BA4AB-ED42-4D6D-881F-CF7250A7E51BQ58703195-165DA7F9-28FB-4F90-AF91-ECC406F04751
P2860
Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Validation of the FAM19A4/mir1 ...... e)cancer in HPV-positive women
@en
type
label
Validation of the FAM19A4/mir1 ...... e)cancer in HPV-positive women
@en
prefLabel
Validation of the FAM19A4/mir1 ...... e)cancer in HPV-positive women
@en
P2093
P2860
P1433
P1476
Validation of the FAM19A4/mir1 ...... e)cancer in HPV-positive women
@en
P2093
Albertus T Hesselink
Chris J L M Meijer
Daniëlle A M Heideman
Folkert J van Kemenade
Helena M E de Bruin
Johannes Berkhof
Leon F A G Massuger
Lise M A De Strooper
Peter J F Snijders
Remko P Bosgraaf
P2860
P304
P356
10.1016/J.YGYNO.2016.02.012
P407
P577
2016-02-24T00:00:00Z